AHA/ACC/SCAI/ACS/ADA/ACP Scientific Advisory
Healthcare providers who perform invasive or surgical procedures on patients who have had coronary stents placed should contact the patient’s cardiologist to discuss optimal management of the patient’s antiplatelet therapy.
Elective procedures where discontinuation of dual antiplatelet therapy is felt necessary should be deferred for 1 month in the case of bare metal stents and 12 months for drug eluting stents.
Patients treated with drug eluting stents that undergo procedures that mandate discontinuation of the thienopyridine (clopidogrel or ticlopidine) should remain on aspirin if at all possible with the thienopyridine restarted as soon as possible post procedure.
Grines, et al. Circulation 2007;115:813-818